iShares NASDAQ US Biotechnology UCITS ETF (LON:BTEE)
London · Delayed Price · Currency is GBP · Price in USD 6.86
-0.05 (-0.76%)
Sep 4, 2025, 4:13 PM BST
LON:BTEE Holdings Information
LON:BTEE is an equity ETF with a total of 263 individual holdings. The top holdings are Gilead Sciences stock at 7.21%, Amgen at 7.02%, Vertex Pharmaceuticals at 6.22%, Regeneron Pharmaceuticals at 6.21%, and Alnylam Pharmaceuticals at 5.15%.
Total Holdings
263
Top 10 Percentage
45.17%
Asset Class
Equity
ETF Category
Health Care
Assets
20.95M
PE Ratio
17.67
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | GILD | Gilead Sciences, Inc. | 7.21% |
| 2 | AMGN | Amgen Inc. | 7.02% |
| 3 | VRTX | Vertex Pharmaceuticals Incorporated | 6.22% |
| 4 | REGN | Regeneron Pharmaceuticals, Inc. | 6.21% |
| 5 | ALNY | Alnylam Pharmaceuticals, Inc. | 5.15% |
| 6 | AZN | AstraZeneca PLC | 4.79% |
| 7 | INSM | Insmed Incorporated | 2.52% |
| 8 | ARGX | argenx SE | 2.29% |
| 9 | BIIB | Biogen Inc. | 1.97% |
| 10 | SMMT | Summit Therapeutics Inc. | 1.79% |
| 11 | INCY | Incyte Corporation | 1.66% |
| 12 | ILMN | Illumina, Inc. | 1.61% |
| 13 | RPRX | Royalty Pharma plc | 1.54% |
| 14 | SNY | Sanofi | 1.41% |
| 15 | NBIX | Neurocrine Biosciences, Inc. | 1.40% |
| 16 | UTHR | United Therapeutics Corporation | 1.39% |
| 17 | MEDP | Medpace Holdings, Inc. | 1.39% |
| 18 | TEM | Tempus AI, Inc. | 1.29% |
| 19 | ONC | BeOne Medicines AG | 1.29% |
| 20 | VTRS | Viatris Inc. | 1.26% |
| 21 | ASND | Ascendis Pharma A/S | 1.20% |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 1.13% |
| 23 | EXEL | Exelixis, Inc. | 1.03% |
| 24 | BNTX | BioNTech SE | 1.01% |
| 25 | BBIO | BridgeBio Pharma, Inc. | 1.00% |
As of Sep 1, 2025